FIELD: medicine. SUBSTANCE: method involves exposing human organism to physical factor acting synchronously with cardiac rhythm. Electromagnetic field is applied for 0.03-0.3 s in cardiac rhythm 0.02 s later than each electrocardiogram T-tooth occurrence with frequency cald from formula , where c is electromagnetic energy propagation speed in air in cm/s; ε is dielectric permeability of blood equal to 81, μ is magnet permeability of blood equal to 1 ; λ0 is the wavelength equal to patient height l0 in cm. Therapeutic action is achieved when organism energy unbalance caused by basic electromagnetic energy deficiency with parameters characteristic of given patient. EFFECT: enhanced effectiveness of treatment and prophylaxis. 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR GENERATING PHYSIOTHERAPEUTIC TREATMENT SIGNAL AND DEVICE FOR CARRYING OUT SAME | 1993 |
|
RU2039579C1 |
CARDIOLOGICAL MAGNETIC LASER THERAPEUTIC APPARATUS | 1991 |
|
RU2022574C1 |
METHOD OF TREATING DIABETIC RETINOPATY IN CHILDREN | 2009 |
|
RU2402357C1 |
METHOD OF CORRECTING FUNCTIONAL STATE OF ORGANISM | 2010 |
|
RU2432972C1 |
METHOD FOR DETERMINING DIAGNOSTIC ULTRASOUND EFFECT IN HUMAN | 2014 |
|
RU2569246C1 |
METHOD FOR EVALUATING SAFETY BELT INFLUENCE EXERTED UPON HUMAN ORGANISM WHEN BEING SUSPENDED IN IT FOR A GIVEN TIME PERIOD | 2004 |
|
RU2272572C2 |
MAGNETIC GRAVITY PHYSIOTHERAPY APPARATUS | 2012 |
|
RU2503440C1 |
PHYSEOTHERAPEUTIC DEVICE | 2007 |
|
RU2395267C2 |
METHOD OF TREATING ADOLESCENTS WITH SYMPATHICOTONIC VASONEUROSIS SYNDROME OR PRIMARY ARTERIAL HYPERTENSIA | 2009 |
|
RU2390323C1 |
METHOD OF MAN'S FUNCTIONAL STATE MONITORING AND RELATED MONITORING DEVICE | 2006 |
|
RU2327415C1 |
Authors
Dates
2002-12-10—Published
1997-07-02—Filed